Chai Discovery
PrivateLast Round
Series C
Jul 14, 2026
Est. Valuation
$3.8B
Total Funding Raised
$630M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Chai Discovery is a biotechnology company that builds generative AI software to predict and reprogram the interactions between biochemical molecules, providing an infrastructure platform for pharmaceutical companies to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chai Discovery Comparables
Compare Chai Discovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMap | 84% | |
| Profluent Bio | 82% | |
| Insilico Medicine | 82% |
For institutional investors. Book with your work email.
Chai Discovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 14, 2026 | ||||
| Series B | Dec 15, 2025 | ||||
| Series A | Aug 6, 2025 | ||||
| Seed | Sep 9, 2024 |
For institutional investors. Book with your work email.
Chai Discovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Ventures | Series C |
| DST Global | Series A |
| Neo | Series B, Seed, Series A |
| SV Angel | Series B, Series A |
| Avra | Series C |
| Oak HC/FT | Series C, Series B |
| Dimension | Series B, Series C, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2026
Collaborating with Roche on AI-driven drug discovery.
- Sep 1, 2026
Grew 17% QoQ, from 36 to 42 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 6, 2026
On Nov 6th '26, Chai Discovery Inc. partners with Roche to use Chai Discovery Inc.'s AI models and platform across multiple drug discovery programs spanning Roche's therapeutic areas.
- partners_withOct 9, 2026
Chai Discovery Inc. and GlaxoSmithKline plc announce a collaboration on Oct 9th '26 after successful wet-lab testing, with GlaxoSmithKline plc gaining access to Chai Discovery Inc.'s protein folding and design models to support discovery across its pipeline.
- partners_withAug 21, 2026
Chai Discovery Inc. and Bristol-Myers Squibb Co partner in California on Aug 20th '26 to use AI-driven molecular folding and design models to support therapeutic antibody discovery across Bristol-Myers Squibb Co's portfolio.
For institutional investors. Book with your work email.
Chai Discovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chai Discovery's valuation, stock price, and market status.
Is Chai Discovery a public or private company?
Chai Discovery is a private company.
What is the current stock price of Chai Discovery?
Chai Discovery is a private company, so its shares have no public market price. Caplight tracks Chai Discovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chai Discovery worth (valuation)?
Chai Discovery's valuation is estimated at $3.8B based on funding round data.
Can I buy Chai Discovery stock?
Chai Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chai Discovery's last funding round?
Chai Discovery's most recent funding round was Series C on July 14, 2026.
Who are the main investors in Chai Discovery?
Key investors in Chai Discovery include Oak HC/FT, Thrive Capital, General Catalyst, Dimension, Index Ventures.
Will Chai Discovery IPO soon?
No public IPO plans have been announced for Chai Discovery.
How can I track Chai Discovery secondary market activity?
Caplight tracks bids, offers, and trades in Chai Discovery's shares on secondary markets.